miR-223: sailing to terra incognita for microRNAs in platelets

Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.

Facebook Linkedin Weibo

PDF herunterladen

Thromb Haemost 2013; 110(06): 1112-1113
DOI: 10.1160/TH13-10-0882

T&H Insight

Schattauer GmbH

Julie Halkein

¹Department of Cardiology, CARIM School for Cardiovascular Diseases, Maastricht University, Maastricht, The Netherlands

,

Leon J. De Windt

¹Department of Cardiology, CARIM School for Cardiovascular Diseases, Maastricht University, Maastricht, The Netherlands

²Department of Cardiology, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, the Netherlands

Weitere Informationen

Received: 28. Oktober 2013

Accepted: 28. Oktober 2013

Publikationsdatum:
30. November 2017 (online)

References
1 Leiderseider S. et al MiR-223 is dispensable for platelet production and function in mice. Thromb Haemost 2013; 110: 1207-1214.

Thieme Connect PubMed Suche in Google Scholar
2 Willeit P. et al. Circulating microRNAs as novel biomarkers for platelet activation. Circulation Res 2013; 112: 595-600.

Crossref PubMed Suche in Google Scholar
3 Laffont B. et al. Activated platelets can deliver mRNA regulatory Ago2*microRNA complexes to endothelial cells via microparticles. Blood 2013; 122: 253-261.

Crossref PubMed Suche in Google Scholar
4 Felli N. et al. MicroRNA 223-dependent expression of LMO2 regulates normal erythropoiesis. Haematologica 2009; 94: 479-486.

Crossref PubMed Suche in Google Scholar
5 Yuan JY. et al. MicroRNA-223 reversibly regulates erythroid and megakaryocytic differentiation of K562 cells. J Cell Mol Med 2009; 13: 4551-4559.

Crossref PubMed Suche in Google Scholar
6 Zampetaki A. et al. Prospective study on circulating MicroRNAs and risk of myocardial infarction. J Am Coll Cardiol 2012; 60: 290-299.

Crossref PubMed Suche in Google Scholar